Methods of testing for intracellular pathogens

Details for Australian Patent Application No. 2011225748 (hide)

Owner Novartis AG

Inventors Tsai, Theodore

Agent FB Rice

Pub. Number AU-A-2011225748

PCT Pub. Number WO2011/110955

Priority 61/339,764 08.03.10 US

Filing date 7 March 2011

Wipo publication date 15 September 2011

International Classifications

C12N 15/11 Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/110955 Priority application(s): WO2011/110955

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011225754-Patient interface device with cheekbone stabilization

2011225747-Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity